| Plasminogen activator inhibitor-1 and tumour growth, invasion, and metastasis MKV Durand, JS Bødker, A Christensen, DM Dupont, M Hansen, ... Thrombosis and haemostasis 91 (03), 438-449, 2004 | 224 | 2004 |
| Biochemical properties of plasminogen activator inhibitor-1 DM Dupont, JB Madsen, T Kristensen, JS Bodker, GE Blouse, T Wind, ... Frontiers in Bioscience-Landmark 14 (4), 1337-1361, 2009 | 137 | 2009 |
| Tumor‐Targeted Polydiacetylene Micelles for In Vivo Imaging and Drug Delivery N Mackiewicz, E Gravel, A Garofalakis, J Ogier, J John, DM Dupont, ... Small 7 (19), 2786-2792, 2011 | 79 | 2011 |
| Methods to identify aptamers against cell surface biomarkers A Cibiel, DM Dupont, F Ducongé Pharmaceuticals 4 (9), 1216-1235, 2011 | 75 | 2011 |
| Nanopore sequencing of brain-derived full-length circRNAs reveals circRNA-specific exon usage, intron retention and microexons K Rahimi, MT Venø, DM Dupont, J Kjems Nature Communications 12 (1), 4825, 2021 | 66 | 2021 |
| Characterisation of aptamer–target interactions by branched selection and high-throughput sequencing of SELEX pools DM Dupont, N Larsen, JK Jensen, PA Andreasen, J Kjems Nucleic acids research 43 (21), e139-e139, 2015 | 64 | 2015 |
| A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry J Valero, L Civit, DM Dupont, D Selnihhin, LS Reinert, M Idorn, BA Israels, ... Proceedings of the National Academy of Sciences 118 (50), e2112942118, 2021 | 63 | 2021 |
| Evidence for a pre-latent form of the serpin plasminogen activator inhibitor-1 with a detached β-strand 1C DM Dupont, GE Blouse, M Hansen, L Mathiasen, S Kjelgaard, JK Jensen, ... Journal of Biological Chemistry 281 (47), 36071-36081, 2006 | 46 | 2006 |
| Nucleic acid aptamers against proteases D M Dupont, L M Andersen, K A Botkjaer, P A Andreasen Current medicinal chemistry 18 (27), 4139-4151, 2011 | 37 | 2011 |
| In vivo validation of free-space fluorescence tomography using nuclear imaging A Garofalakis, A Dubois, B Kuhnast, DM Dupont, I Janssens, ... Optics letters 35 (18), 3024-3026, 2010 | 34 | 2010 |
| RNA aptamers as conformational probes and regulatory agents for plasminogen activator inhibitor-1 JB Madsen, DM Dupont, TB Andersen, AF Nielsen, L Sang, DM Brix, ... Biochemistry 49 (19), 4103-4115, 2010 | 34 | 2010 |
| Mutational analysis of plasminogen activator inhibitor‐1: Interactions of α‐helix F and its neighbouring structural elements regulates the activity and the rate of latency … T Wind, JK Jensen, DM Dupont, P Kulig, PA Andreasen European journal of biochemistry 270 (8), 1680-1688, 2003 | 33 | 2003 |
| An albumin-oligonucleotide assembly for potential combinatorial drug delivery and half-life extension applications M Kuhlmann, JBR Hamming, A Voldum, G Tsakiridou, MT Larsen, ... Molecular Therapy-Nucleic Acids 9, 284-293, 2017 | 32 | 2017 |
| Construction of a plasminogen activator inhibitor‐1 variant without measurable affinity to vitronectin but otherwise normal JK Jensen, MKV Durand, S Skeldal, DM Dupont, JS Bødker, T Wind, ... FEBS letters 556 (1-3), 175-179, 2004 | 32 | 2004 |
| Dissecting the effect of RNA aptamer binding on the dynamics of plasminogen activator inhibitor 1 using hydrogen/deuterium exchange mass spectrometry MB Trelle, DM Dupont, JB Madsen, PA Andreasen, TJD Jørgensen ACS chemical biology 9 (1), 174-182, 2014 | 30 | 2014 |
| Serum-stable RNA aptamers to urokinase-type plasminogen activator blocking receptor binding DM Dupont, JB Madsen, RK Hartmann, B Tavitian, F Ducongé, J Kjems, ... RNA 16 (12), 2360-2369, 2010 | 29 | 2010 |
| Interactions of plasminogen activator inhibitor-1 with vitronectin involve an extensive binding surface and induce mutual conformational rearrangements GE Blouse, DM Dupont, CR Schar, JK Jensen, KH Minor, JY Anagli, ... Biochemistry 48 (8), 1723-1735, 2009 | 27 | 2009 |
| Protein-binding RNA aptamers affect molecular interactions distantly from their binding sites DM Dupont, CK Thuesen, KA Bøtkjær, MA Behrens, K Dam, HP Sørensen, ... PloS one 10 (3), e0119207, 2015 | 26 | 2015 |
| A peptide accelerating the conversion of plasminogen activator inhibitor-1 to an inactive latent state L Mathiasen, DM Dupont, A Christensen, GE Blouse, JK Jensen, A Gils, ... Molecular pharmacology 74 (3), 641-653, 2008 | 26 | 2008 |
| Expected and unexpected features of protein‐binding RNA aptamers N Bjerregaard, PA Andreasen, DM Dupont Wiley Interdisciplinary Reviews: RNA 7 (6), 744-757, 2016 | 25 | 2016 |
